Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH

被引:55
作者
Fredrickson, Gavin [1 ]
Barrow, Fanta [1 ]
Dietsche, Katrina [1 ]
Parthiban, Preethy [1 ]
Khan, Saad [2 ,3 ]
Robert, Sacha [1 ]
Demirchian, Maya [1 ]
Rhoades, Hailey [1 ]
Wang, Haiguang [1 ]
Adeyi, Oyedele [4 ]
Revelo, Xavier S. [1 ,5 ]
机构
[1] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA
[2] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada
[3] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON M5G 1L7, Canada
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA
来源
MOLECULAR METABOLISM | 2021年 / 53卷
关键词
NASH; NAFLD; Exercise; HIIT; Inflammation; FATTY LIVER-DISEASE; DIET-INDUCED-OBESITY; NONALCOHOLIC STEATOHEPATITIS; MACROPHAGE INFILTRATION; INSULIN-RESISTANCE; INTERVAL EXERCISE; RECEPTOR; INCREASES; MODERATE; FIBROSIS;
D O I
10.1016/j.molmet.2021.101270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Non-alcoholic fatty liver disease (NAFLD) covers a wide spectrum of liver pathology ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH). Notably, immune cell-driven inflammation is a key mechanism in the transition from fatty liver to the more serious NASH. Although exercise training is effective in ameliorating obesity-related diseases, the underlying mechanisms of the beneficial effects of exercise remain unclear. It is unknown whether there is an optimal modality and intensity of exercise to treat NAFLD. The objective of this study was to determine whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MIT) is more effective at ameliorating the progression of NASH. Methods: Wild-type mice were fed a high-fat, high-carbohydrate (HFHC) diet for 6 weeks and left sedentary (SED) or assigned to either an MIT or HIIT regimen using treadmill running for an additional 16 weeks. MIT and HIIT groups were pair-fed to ensure that energy intake was similar between the exercise cohorts. To determine changes in whole-body metabolism, we performed insulin and glucose tolerance tests, indirect calorimetry, and magnetic resonance imaging. NASH progression was determined by triglyceride accumulation, expression of inflammatory genes, and histological assessment of fibrosis. Immune cell populations in the liver were characterized by cytometry by time-of -flight mass spectrometry, and progenitor populations within the bone marrow were assessed by flow cytometry. Finally, we analyzed the transcriptional profile of the liver by bulk RNA sequencing. Results: Compared with SED mice, both HIIT and MIT suppressed weight gain, improved whole-body metabolic parameters, and ameliorated the progression of NASH by reducing hepatic triglyceride levels, inflammation, and fibrosis. However, HIIT was superior to MIT at reducing adiposity, improving whole-body glucose tolerance, and ameliorating liver steatosis, inflammation, and fibrosis, without any changes in body weight. Improved NASH progression in HIIT mice was accompanied by a substantial decrease in the frequency of pro-inflammatory infiltrating, monocyte-derived macrophages in the liver and reduced myeloid progenitor populations in the bone marrow. Notably, an acute bout of MIT or HIIT exercise had no effect on the intrahepatic and splenic immune cell populations. In addition, bulk mRNA sequencing of the entire liver tissue showed a pattern of gene expression confirming that HIIT was more effective than MIT in improving liver inflammation and lipid biosynthesis. Conclusions: Our data suggest that exercise lessens hepatic inflammation during NASH by reducing the accumulation of hepatic monocyte-derived inflammatory macrophages and bone marrow precursor cells. Our findings also indicate that HIIT is superior to MIT in ameliorating the disease in a dietary mouse model of NASH. (c) 2021 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
    Ding, Zhi-Ming
    Xiao, Yue
    Wu, Xikun
    Zou, Haixia
    Yang, Shurong
    Shen, Yiyun
    Xu, Juehua
    Workman, Heather C.
    Usborne, Amy L.
    Hua, Haiqing
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [22] Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
    Liu, Qiuhong
    Li, Han
    He, Weiwei
    Zhao, Qing
    Huang, Caoxin
    Wang, Qingxuan
    Zheng, Zeyu
    Zhang, Xiaofang
    Shi, Xiulin
    Li, Xuejun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [23] Adaptive Immune Responses Triggered by Oxidative Stress Contribute to Hepatic Inflammation in NASH
    Sutti, Salvatore
    Jindal, Aastha
    Locatelli, Irene
    Vacchiano, Marco
    Gigliotti, Luca
    Bozzola, Cristina
    Albano, Emanuele
    HEPATOLOGY, 2014, 59 (03) : 886 - 897
  • [24] Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice
    Duan, Jingjing
    Wang, Zhuo
    Duan, Ran
    Yang, Chenxinhui
    Zhao, Ruolin
    Feng, Qi
    Qin, Yuanyuan
    Jiang, Jingwei
    Gu, Shouyong
    Lv, Kaiyan
    Zhang, Libo
    He, Bixia
    Birnbaumer, Lutz
    Yang, Song
    Chen, Zhen
    Yang, Yong
    HEPATOLOGY, 2022, 75 (01) : 140 - 153
  • [25] Hepatic damage caused by long-term high cholesterol intake induces a dysfunctional restorative macrophage population in experimental NASH
    Maretti-Mira, Ana C.
    Salomon, Matthew P.
    Hsu, Angela M.
    Kanel, Gary C.
    Golden-Mason, Lucy
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model
    Sabir, Usman
    Irfan, Hafiz Muhammad
    Alamgeer
    Ullah, Aman
    Althobaiti, Yusuf S.
    Alshehri, Fahad S.
    Niazi, Zahid Rasul
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [27] Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis
    Xu, Jiesi
    Chen, Siyu
    Wang, Wei
    Lam, Sin Man
    Xu, Yang
    Zhang, Shaohua
    Pan, Huimin
    Liang, Jingjing
    Huang, Xiahe
    Wang, Yu
    Li, Ting
    Jiang, Yuqiang
    Wang, Yingchun
    Ding, Mei
    Shui, Guanghou
    Yang, Hongyuan
    Huang, Xun
    SCIENCE BULLETIN, 2022, 67 (03) : 299 - 314
  • [28] Macrophage Stimulating Protein Enhances Hepatic Inflammation in α NASH Model
    Li, Jieyi
    Chanda, Dipanjan
    van Gorp, Patrick J.
    Jeurissen, Mike L. J.
    Houben, Tom
    Walenbergh, Sofie M. A.
    Debets, Jacques
    Oligschlaeger, Yvonne
    Gijbels, Marion J. J.
    Neumann, Dietbert
    Shiri-Sverdlov, Ronit
    PLOS ONE, 2016, 11 (09):
  • [29] Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways
    Hong, Moonju
    Jung, Jeeyoun
    Park, Hee-Sook
    Lee, So Min
    Jeong, Nam-Joo
    Kim, Soon-Hee
    Lee, Kyoung-Won
    Lee, Ju-A
    Kim, Myung-Sunny
    PLOS ONE, 2017, 12 (06):
  • [30] Effect of high-intensity exercise on aerobic performance and airway inflammation in asthma
    Winn, Charles
    McNarry, Melitta
    Stratton, Gareth
    Wilson, Andrew
    Davies, Gwyneth
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48